Weill Cornell Medicine Researchers Discover New Mechanism to Combat Gut Inflammation
Researchers at Weill Cornell Medicine have identified a novel mechanism by which the immune system regulates chronic inflammation in the gut. The study, published in the Journal of Experimental Medicine, reveals that blocking a specific immune signal, rather than activating it, can promote tolerance in the intestine and significantly reduce inflammation. This discovery challenges previous assumptions about immune tolerance and could lead to new treatments for inflammatory bowel disease (IBD), food allergies, and other autoimmune disorders. The research focused on the role of regulatory T cells (Treg cells) and antigen-presenting cells (APCs) in maintaining immune balance in the gut. The study found that blocking the 'Second Signal' in T cell activation, while maintaining the 'First Signal,' increased the number of Treg cells and protected against intestinal inflammation in preclinical models. 
